跳至主要内容
临床试验/ACTRN12605000765628
ACTRN12605000765628已完成不适用

A randomised clinical trial of different infusion rates of magnesium sulphate given prenatally to women for the prevention of side effects.

ARCH: Australian Research Centre for Health of Women and Babies, The Robinson Institute, The University of Adelaide0 个研究点目标入组 51 人开始时间: 2005年11月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
51

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
ot stated 至 ot stated(—)
性别
Female

入选标准

  • Women who are now recommended magnesium sulphate as per the National Clinical Practice Guidelines, and the South Australian Perinatal Practice Guidelines: a gestational age of less than 30 weeks where birth is planned or definitely expected within 24 hours. The women must have a singleton or twin pregnancy.

排除标准

  • 1)Women with the following contraindications to magnesium sulphate: absent patellar reflexes, hypocalcaemia, respiratory rate < 16/minute, renal failure, urine output < 100mls during the last 4 hours;
  • 2)Women who are in the second stage of labour;
  • 3)Women who have already been given magnesium sulphate therapy in this pregnancy.

研究者

发起方
ARCH: Australian Research Centre for Health of Women and Babies, The Robinson Institute, The University of Adelaide

相似试验

已完成
3 期
A clinical trial comparing low dose versus standard dose of intravenous paracetamol for PDA closure in very premature babies
CTRI/2017/10/010012Surya Childrens Medicare Private limited102
已完成
不适用
Screening and Intervention Programme for Sensible drinking - Accident and Emergency DepartmentMental and behavioural disorders due to use of alcoholAlcohol use disorders/accident and emergencyMental and Behavioural Disorders
ISRCTN93681536Institute of Psychiatry, Kings College London (UK)1,179
进行中(未招募)
不适用
Treatment of second degree burns with Flaminal® versus Flammazine®Patients with partial thickness burns and/ or mixed depth of partial and full thickness burnsMedDRA version: 14.1Level: LLTClassification code 10015723Term: Extensive burnsSystem Organ Class: 100000004863MedDRA version: 14.1Level: LLTClassification code 10006796Term: Burns eyesSystem Organ Class: 100000004863MedDRA version: 14.1Level: LLTClassification code 10006795Term: Burns extensiveSystem Organ Class: 100000004863MedDRA version: 16.0Level: LLTClassification code 10006794Term: Burns classified according to extent of body surface involvedSystem Organ Class: 100000004863MedDRA version: 14.1Level: LLTClassification code 10043441Term: Third degree burnsSystem Organ Class: 100000004863MedDRA version: 14.1Level: LLTClassification code 10006801Term: Burns of multiple specified sites, unspecified degreeSystem Organ Class: 100000004863MedDRA version: 16.0Level: LLTClassification code 10012087Term: Deep necrosis of underlying tissues due to burns (dtd) of multiple specified sites w/o mention lobpSystem Organ Class: 100000004863MedDRA version: 14.1Level: LLTClassification code 10028175Term: Multiple burnsSystem Organ Class: 100000004863MedDRA version: 14.1Level: LLTClassification code 10039798Term: Second degree burnsSystem Organ Class: 100000004863MedDRA version: 16.0Level: LLTClassification code 10031700Term: Other burns of eyelids and periocular areaSystem Organ Class: 100000004863
EUCTR2013-000901-21-NLRode Kruis Ziekenhuis
招募中
不适用
Flaminal® versus Flammazine® in the treatment of superficial and deep partial thickness burns (Flam study)Flammazine®, Flaminal®, wound healing, partial thickness burnsFlammazine®, Flaminal®, wondgenezing, tweedegraads brandwonden
NL-OMON27618eiden University Medical Center (LUMC)90
已完成
不适用
A randomized clinical trial on the effectiveness, cost-effectiveness and quality of life of Flaminal® versus Flammazine® in the treatment of superficial and deep partial thickness burns.
NL-OMON40281Rode Kruis Ziekenhuis90